Keywords: good, first, quarter, novo, nordisk, achieved, turnover
Good First Quarter For Novo Nordisk
Article | 15 May 1995
Novo Nordisk achieved turnover in the first quarter of 1995 of 3.4 billion Danish kroner ($621.2 million), up 9% on the year-earlier quarter. Net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
